EXSCIENTIA
Exscientia is applying AI and big data processing to accelerate drug discovery and development. At the forefront of small molecule drug discovery. They are the first company to automate drug design, surpassing conventional human endeavor. Their AI-driven systems actively learn best practice from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, their... knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME and other key criteria. From this, a selection of the best, information-rich compounds are selected for synthesis and assay. With new experimental data generated, the results are integrated and the next design cycle initiated. Rapid design-make-test cycles ensure unparalleled progress towards desired project goals. Exscientia has already delivered exceptional productivity, generating candidates in roughly one-quarter of the time of traditional approaches.
EXSCIENTIA
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.exscientia.ai
Total Employee:
101+
Status:
Active
Contact:
+44-1865-818941
Email Addresses:
[email protected]
Total Funding:
474.37 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon Google Apps For Business Microsoft Azure DNS GoDaddy DNS Pound Sterling Amazon S3 CDN Japanese Yen Amazon Ireland Region
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-15 | Allcyte | Allcyte acquired by Exscientia | 50 M EUR |
| 2018-11-15 | Kinetic Discovery Ltd. | Kinetic Discovery Ltd. acquired by Exscientia | N/A |
Investors List
Sanofi
Sanofi investment in Post-IPO Equity - Exscientia
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Exscientia
Hongyou Investment
Hongyou Investment investment in Series D - Exscientia
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Series D - Exscientia
Novo Holdings
Novo Holdings investment in Series D - Exscientia
Marshall Wace
Marshall Wace investment in Series D - Exscientia
BlackRock
BlackRock investment in Series D - Exscientia
Bristol Myers Squibb
Bristol Myers Squibb investment in Series D - Exscientia
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series D - Exscientia
SoftBank Vision Fund
SoftBank Vision Fund investment in Series D - Exscientia
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-05 | Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer |
| 2022-01-19 | Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI |
| 2021-10-01 | Exscientia debuts IPO |
Official Site Inspections
http://www.exscientia.ai Semrush global rank: 1.37 M Semrush visits lastest month: 21.06 K
- Host name: 83-223-102-104.as29017.net
- IP address: 83.223.102.104
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
